CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.150

+2.7%

Nov 25 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Johan Van Houtven who wrote (26)	2/14/1997 8:28:00 PM
From: A.J. Mullen	of 668

To my mind "neutral" = negative. To be approved by the FDA, a drug or device has to be shown to be to be significantly better than what's already on the market. It seemed to me that a CEO saying his product was equivalent to one already established was surprising. Usually there is some parameter that is better, and this is stressed. Perhaps this was an honest no-hype presentation to medics. As I say, I was surprised. I sold, and locked in a 75% gain. I was already somewhat concerned that, although there are many developments in the pipeline, they all seem to be based on one molecule. Can anyone comment on that? Not panicked, just cautious but ready to be re-convinced. AJ

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next